BOOSTER THERAPEUTICS Trademark

Trademark Overview


On Monday, March 14, 2022, a trademark application was filed for BOOSTER THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the BOOSTER THERAPEUTICS trademark a serial number of 97312047. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Wednesday, January 3, 2024. This trademark is owned by Booster Therapeutics GmbH. The BOOSTER THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases; Compound drugs and pharmaceuticals for the use in the field of oncology, immunology, inflammatory diseases, and central nervous system disorders to treat the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunc...

Medical laboratory services; Biological research; Clinical research in the field the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases, by degrading disease-causing cellular proteins; Medical research; Scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical products; Research and development for the pharmaceutical industry; Consultancy relating to pharmaceutical research and development; Scientific and technological services, namely, scientific research, analysis and testing research in the field the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases...
booster therapeutics

General Information


Serial Number97312047
Word MarkBOOSTER THERAPEUTICS
Filing DateMonday, March 14, 2022
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateWednesday, January 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases; Compound drugs and pharmaceuticals for the use in the field of oncology, immunology, inflammatory diseases, and central nervous system disorders to treat the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases, by degrading disease-causing cellular proteins; Compound drugs and pharmaceuticals for the treatment of the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases, by degrading disease-causing cellular proteins; Biological reagents for medical use; Cellular function activating agents for medical purposes; Chemical reagents for medical use; Clinical diagnostic reagents; Diagnostic testing materials for medical use, namely, Diagnostic reagents for medicinal use; Diagnostic substances for medical use; Disinfectants and antiseptics; Drug delivery agents, namely, Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Arsenic, Benzol and Chlorine detoxification agents for medical purposes; Drugs being pharmaceuticals, medical and veterinary preparations for the treatment of for the treatment of the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases, caused by degrading disease-causing cellular proteins; Enzymes for medical purposes; General anaesthetics; Pharmaceuticals, medical and veterinary preparations for the treatment of for the treatment of the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases, caused by degrading disease-causing cellular proteins; Sanitary preparations for medical purposes; Food for babies; Dietary supplements for human beings and animals; Sticking plasters for medical purposes; Materials for medical and surgical dressings; Material for stopping teeth; Dental wax; Disinfectants; Preparations for destroying vermin; Fungicides; Herbicides
Goods and ServicesMedical laboratory services; Biological research; Clinical research in the field the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases, by degrading disease-causing cellular proteins; Medical research; Scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical products; Research and development for the pharmaceutical industry; Consultancy relating to pharmaceutical research and development; Scientific and technological services, namely, scientific research, analysis and testing research in the field the pathologies of aging, neurodegenerative diseases, brain diseases, ocular diseases, skin disorders and skin conditions, kidney diseases, liver diseases , heart diseases, urology disorders, circulatory disorders, muscle diseases, pancreas diseases, digestive system diseases, lung diseases, memory loss, fatigue, eye strain, eye disease, hearing loss, hair loss, sexual disfunction and reproductive system diseases, by degrading disease-causing cellular proteins, and scientific research and Design of computer software relating thereto; Application service provider, namely, Providing online non-downloadable computer software platforms for medical research in the field of drug discovery and drug development; Programming of a drug discovery and development computer software platform for others; Online electronic data storage; Consultancy and assistance services in the nature of website design consultancy and computer software consulting, via an online website and data network platform, in the field of medical sciences including cell metabolism, aging and cell health; Computer services, namely, hosting of an online platform in the nature of online web facilities for the archiving, evaluation, analysation and exchange of data in the fields of biological research, clinical research and medical research

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 18, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBooster Therapeutics GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBerlin D-10629
DE

Trademark Events


Event DateEvent Description
Wednesday, January 3, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, May 2, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, May 2, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, May 2, 2023SUSPENSION LETTER WRITTEN
Tuesday, April 4, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 3, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 3, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 3, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 3, 2023NON-FINAL ACTION E-MAILED
Tuesday, January 3, 2023NON-FINAL ACTION WRITTEN
Friday, December 23, 2022ASSIGNED TO EXAMINER
Friday, March 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 17, 2022NEW APPLICATION ENTERED